✦ LIBER ✦

Pseudomonas aeruginosablepharoconjunctivitis during cytoreductive chemotherapy in a woman with acute lymphocytic leukemia

✍ Scribed by A. A. N. Giagounidis; G. Meckenstock; S. Flacke; M. Burk; A. Wehmeier; C. Aul; W. Schneider

Publisher: Springer
Year: 1997
Tongue: English
Weight: 436 KB
Volume: 75
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770050325

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute myocardial infarction in a patient

Acute myocardial infarction in a patient with chronic myelocytic leukemia during chemotherapy with hydroxyurea

✍ H. Kälsch; H. Wieneke; R. Erbel 📂 Article 📅 2010 🏛 Urban and Vogel 🌐 German ⚖ 269 KB

Intensive induction and consolidation ch

Intensive induction and consolidation chemotherapy in a young woman with acute myeloid leukemia and severe chronic renal failure

✍ T. P. Hardegger; A. von Rohr; A. Tobler; M. F. Fey 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 783 KB

Relation between the duration of remissi

Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate–cytarabine regimen

✍ Mary Ann Weiser; Maria E. Cabanillas; Marina Konopleva; Deborah A. Thomas; Sherr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

## Abstract ## BACKGROUND Hyperglycemia, which is not uncommon during the treatment of acute lymphocytic leukemia (ALL), has been shown to be an independent predictor of adverse outcomes among hospitalized patients with undiagnosed diabetes; it also may have the potential to affect leukemic cell p

A scoring system to predict the risk of

A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia

✍ David Valcárcel; Pau Montesinos; Isabel Sánchez-Ortega; Salut Brunet; Jordi Este 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

## Abstract ## BACKGROUND: A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed. ## METHODS: The authors analyzed 570 patients (aged 16‐70 years) included in 2 multicenter trials of the CETLAM Grou